AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Insights on the Enteric Disease Testing Global Market to 2027 - Featuring Alere, bioMerieux and DiaSorin Among Others - ResearchAndMarkets.com

December 22, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 22, 2020--

The “Enteric Disease Testing - Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

The publisher brings years of research experience to the 9th edition of this report. The 281-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

ADVERTISEMENT

Global Enteric Disease Testing Market to Reach $4.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Enteric Disease Testing estimated at US$3.8 Billion in the year 2020, is projected to reach a revised size of US$4.5 Billion by 2027, growing at a CAGR of 2.3% over the analysis period 2020-2027.

Immunoassay Testing, one of the segments analyzed in the report, is projected to record a 3.1% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Conventional Testing segment is readjusted to a revised 1.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1 Billion, While China is Forecast to Grow at 4.4% CAGR

The Enteric Disease Testing market in the U.S. is estimated at US$1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$893.6 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.4% and 1.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.

Molecular Diagnostic Testing Segment to Record 2.4% CAGR

In the global Molecular Diagnostic Testing segment, USA, Canada, Japan, China and Europe will drive the 2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1 Billion in the year 2020 will reach a projected size of US$1.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$607.7 Million by the year 2027, while Latin America will expand at a 3.2% CAGR through the analysis period.

ADVERTISEMENT

Competitors identified in this market include, among others:

  • Alere, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CorisBioconcept SPRL
  • DiaSorin, Inc.
  • Meridian Bioscience, Inc.
  • Pro-Lab Diagnostics, Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.
  • Trinity Biotech PLC

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Enteric Disease Testing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 44

For more information about this report visit https://www.researchandmarkets.com/r/4gltt4

View source version on businesswire.com:https://www.businesswire.com/news/home/20201222005519/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH ENVIRONMENT OTHER SCIENCE RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/22/2020 11:13 AM/DISC: 12/22/2020 11:13 AM

http://www.businesswire.com/news/home/20201222005519/en